Endpoints News 6 abr 2026 Stipple Bio launches with $100M to find more precise targets on cancer proteins
Endpoints News 11 feb 2026 Upstream Bio says verekitug delivered positive data in Phase 2 severe asthma trial
Endpoints News 9 dic 2025 Stealthy biotech Sidera Bio raises $109M; Assembly's data for oral herpes drugs
Endpoints News 1 dic 2025 Belite Bio aims for first approval of Stargardt disease treatment with Phase 3 success